{
    "paper_id": "43d1ea78fb9a694f81e590f387cbcff0b7d0073f",
    "metadata": {
        "title": "Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence Technical Appendix Estimation of Immunosuppressed Population",
        "authors": [
            {
                "first": "",
                "middle": [],
                "last": "Sydney",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Australia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "(9) and 7.84% (10) of the population, respectively. Persons living with autoimmune diseases and dialysis were estimated to be 7.37% (11) and 0.14% (12) , respectively. We distributed dialysis treatment prevalence by age (6) and autoimmune diseases by rheumatoid arthritis age-specific incidence.",
            "cite_spans": [
                {
                    "start": 132,
                    "end": 136,
                    "text": "(11)",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 147,
                    "end": 151,
                    "text": "(12)",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 220,
                    "end": 223,
                    "text": "(6)",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "At any point in time, a fraction of cancer patients receiving chemotherapy will be severely immunosuppressed; we estimated this fraction to be 6.7% of persons with cancer (1).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Division of Estimated Immunosuppressed Population into Different Immunologic Levels"
        },
        {
            "text": "We classified this fraction as severely immunosuppressed and the remaining 93.3% as mild.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Division of Estimated Immunosuppressed Population into Different Immunologic Levels"
        },
        {
            "text": "We considered 30% of the persons in Sydney and 40% of the persons in New York living with HIV, 100% of persons living with organ transplant, and 33% of the population effected by autoimmune diseases to be severely immunocompromised (Technical Appendix Table 1 ). The mildly immunocompromised compartment comprised the rest of the population living with HIV (70%-60%), autoimmune diseases (67%), cancer (97.3%), and renal dialysis (100%). Use of inhaled corticosteroids is immunosuppressive to the respiratory tract and associated with a higher incidence of pneumonia. We divided the population affected by COPD and asthma into the severe (12.3%) and mildly immunocompromised (39.2%) and considered the rest (48.5%) not immunosuppressed.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 252,
                    "end": 259,
                    "text": "Table 1",
                    "ref_id": null
                }
            ],
            "section": "Division of Estimated Immunosuppressed Population into Different Immunologic Levels"
        },
        {
            "text": "Persons infected with hemorrhagic and flat smallpox have the highest basic reproduction number estimated from different historical outbreaks (R0 = 10) (13); however, we used an R0 of 5 to account for the isolation of severely ill patients (Technical Appendix Table 2 ). For ordinary smallpox, we assumed an R0 of 7.96, estimated from a detailed study of an outbreak in Nigeria in a unvaccinated community (14) , and for modified smallpox, we assumed an R0 of 5.3 (2/3 of the R0 estimated for the ordinary type). Because of milder symptoms, we accounted for isolation and halved R0 from the third and fourth day for ordinary and modified smallpox, respectively. Data collected from historical outbreaks (15) shows that persons infected with hemorrhagic, flat, and vaccine-modified smallpox have 100%, 90%, and 0% case fatality ratios (CFRs), respectively, while for ordinary smallpox, infection is age-specific (15) . Another study showed the CFR for hemorrhagic type being 95% (16) . In our study, due to better outbreak response and more developed care centers, we assumed the same CFR for ordinary and vaccine-modified smallpox, but a slightly lower CFR for hemorrhagic and flat cases, being 90% and 75%, respectively.",
            "cite_spans": [
                {
                    "start": 405,
                    "end": 409,
                    "text": "(14)",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 702,
                    "end": 706,
                    "text": "(15)",
                    "ref_id": null
                },
                {
                    "start": 910,
                    "end": 914,
                    "text": "(15)",
                    "ref_id": null
                },
                {
                    "start": 977,
                    "end": 981,
                    "text": "(16)",
                    "ref_id": "BIBREF16"
                }
            ],
            "ref_spans": [
                {
                    "start": 259,
                    "end": 266,
                    "text": "Table 2",
                    "ref_id": null
                }
            ],
            "section": "Disease Type"
        },
        {
            "text": "All the parameters used in the SEIR model are listed in Technical Appendix Table 2 .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 75,
                    "end": 82,
                    "text": "Table 2",
                    "ref_id": null
                }
            ],
            "section": "Model Parameters"
        },
        {
            "text": "We used age-specific rates for hemorrhagic, flat, and ordinary smallpox as estimated by Rao (15) . To get age-specific rates for all age groups up to the >85-year age group, we linearly interpolated the values for the age group available from data collected. The age-specific rates used in the model for each age group of the healthy unvaccinated population are shown in Technical Appendix Table 3 .",
            "cite_spans": [
                {
                    "start": 88,
                    "end": 96,
                    "text": "Rao (15)",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 390,
                    "end": 397,
                    "text": "Table 3",
                    "ref_id": null
                }
            ],
            "section": "Age Distribution Rates of Each Smallpox Disease Type"
        },
        {
            "text": "For the mildly immunosuppressed population, we doubled the age-specific rates of severe smallpox types (Technical Appendix Table 2 ), while for the severely immunosuppressed population, we set at 100% because only the hemorrhagic type develops. Regarding the vaccinated subgroup of the population, an estimated 25.3% of vaccinated persons get vaccinemodified smallpox (15) . We applied a waning immunity function over time at a rate of 1.41%",
            "cite_spans": [
                {
                    "start": 368,
                    "end": 372,
                    "text": "(15)",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 103,
                    "end": 130,
                    "text": "(Technical Appendix Table 2",
                    "ref_id": null
                }
            ],
            "section": "Age Distribution Rates of Each Smallpox Disease Type"
        },
        {
            "text": "per year after vaccination (17). We applied the same waning for the susceptibility as well, starting with a 100%-effective vaccination. Age-specific rates for this subgroup are shown in Technical Appendix Table 4 ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 205,
                    "end": 212,
                    "text": "Table 4",
                    "ref_id": null
                }
            ],
            "section": "Age Distribution Rates of Each Smallpox Disease Type"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Cancer in Australia statistics",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "New South Wales Ministry of Health. NSW HIV strategy",
            "authors": [],
            "year": 2012,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Australian Institute of Health and Welfare. Chronic diseases data",
            "authors": [],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Australia and New Zealand dialysis and transplant registry",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mcdonald",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Excell",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "The Queen Elizabeth Hospital",
            "authors": [
                {
                    "first": "Adelaide",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "South",
                    "middle": [],
                    "last": "Australia",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Australasian Society of Clinical Immunology and Allergy. Autoimmune diseases",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Diagnoses of HIV infection in the United States and dependent areas",
            "authors": [],
            "year": 2015,
            "venue": "HIV Surv Rep",
            "volume": "27",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Department of Health. NYS cancer registry and cancer statistics",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Annual reports. A look back at UNOS' achievements",
            "authors": [],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Most recent asthma data",
            "authors": [],
            "year": 2017,
            "venue": "Centers for Disease Control and Prevention",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Smallpox and its eradication. Geneva: World Health Organization",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Fenner",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Henderson",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Arita",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Je\u017eek",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "D"
                    ],
                    "last": "Ladnyi",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Bynum",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Somers",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Autoimmun",
            "volume": "33",
            "issn": "",
            "pages": "197--207",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jaut.2009.09.008"
                ]
            }
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "World Health Organization. Smallpox",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Transmission potential of smallpox: estimates based on detailed data from an outbreak",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Eichner",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dietz",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Am J Epidemiol",
            "volume": "158",
            "issn": "",
            "pages": "110--117",
            "other_ids": {
                "DOI": [
                    "10.1093/aje/kwg103"
                ]
            }
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Modelling and Bayesian analysis of the Abakaliki smallpox data",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Stockdale",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kypraios",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Neill",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "D"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Epidemics",
            "volume": "19",
            "issn": "",
            "pages": "13--23",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "USAMRIID's medical management of biological casualties handbook",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Christopher",
                    "middle": [
                        "Gw"
                    ],
                    "last": "Cieslak",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Culpepper",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Darling",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pavlin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Nishiura H, Eichner M. Infectiousness of smallpox relative to disease age: estimates based on transmission network and incubation period. Epidemiol Infect. 2007;135:1145-50. PubMed http://dx.doi.org/10.1017/S0950268806007618 18. Australian Bureau of Statistics. 3105.0.65.001 -Australian historical population statistics, 2014. 2014 Sep 18 [cited 2017 Mar 14]. http://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3105.0.65.001 19. Koblentz GD. The de novo synthesis of horsepox virus: implications for biosecurity and recommendations for preventing the reemergence of smallpox. Health Secur. 2017;15:620-8. PubMed http://dx.doi.org/10.1089/hs.2017.0061 Technical Appendix Table 1. Estimation of immunosuppressed population, by disease and immunosuppression level, New York, NY, USA, and Sydney, Australia Technical AppendixTable 3. Distribution rates of hemorrhagic and flat smallpox for healthy unvaccinated infected persons, by age, New York, NY, USA, and Sydney, Australia Technical AppendixTable 4. Distribution rates of hemorrhagic, flat, and vaccine-modified smallpox for healthy vaccinated infected persons, by age, New York, NY, USA, and Sydney, Australia",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}